CONFERENCES

      Grasmere Heterocyclic and Synthesis Meeting

      This is a biennial conference focusing on the synthesis of heterocycles, their properties, and their applications, with topics ranging from innovative reaction pathways to synthesis methodologies. The conference is aimed at scientists, academics, researchers, and industry experts, and provides a forum for sharing and collaborating to identify future trends in the field. 

      21st Grasmere 2013

      Date

      May 09, 2013 - May 13, 2013

      Location

      Grasmere, U.K.

      At this event, PMI scientists present the esearch on identifying 6-aryl-β-carbolines as potent cytotoxic agents with an in vivo anti-tumour activity.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.